Implantation of bitoric MICS IOL after CO-MICS to correct keratoconus

Article

Case study report

Materials and methods

OD: +2.00 -5.50 72 BCVA: 0.25

OS: +2.25 -3.25 138 BCVA: 0.33

After we had discussed different alternatives we decided to implant a bitoric customized toric IOL: AT. Torbi from Carl Zeiss Meditec (Jena, Germany). All the relevant data were entered into the CZM Online Calculator and a customized bitoric IOL was suggested.

The patient's eye reference axis and target axis were marked with a Tabo scheme CZM ocular with the Nd:YAG Laser. We prefer this method in comparison to any marker because it is much more convenient for the patient and can be less influenced by the patient, by rotating the eyeball or retracting the head. After we had done coaxial microincision phacoemulsification (COMICS, OS3 - Oertli Instrumente, Berneck, Switzerland) we implanted the bitoric IOL through a 1.6 mm incision with a wound assisted on axis technique under irrigation without the use of OVD. The orientation of the IOL was checked with a Breyer screen transparency (STACY).

Aberrometry and subjective refraction was tested 2 weeks postop: we achieved a perfect and acceptable result on the OD respective of OS.

Results

Conclusion

The implantation of customized bitoric MICS IOL through a 1.6 mm incision after CO-MICS seems to be a reliable tool to correct astigmatism in keratoconic cataract eyes.

Dr med. Detlev R.H. Breyer is a specialist in cataract and refractive surgery and is senior surgeon at the Breyer Eye Surgery, Dusseldorf, Germany. He may be reached by Email: d.breyer@breyer-augenchirurgie.de

Dr Breyer is a consultant to Oertli and Carl Zeiss Meditec.

References

1. J. Venter, J. Refract. Surg., 2009;25:759–764.

2. K.Kamiya, J. Refract. Surg., 2008;24:840–842.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
3 experts are featured in this series.
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Sunita Radhakrishnan, MD, an associate at the Glaucoma Center of San Francisco, speaks at the annual Glaucoma 360 meeting about electrical neurostimulation.
Related Content
© 2025 MJH Life Sciences

All rights reserved.